Adrenergic drugs 2017

docpravin 6,772 views 28 slides Feb 06, 2018
Slide 1
Slide 1 of 28
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28

About This Presentation

Lecture presentation


Slide Content

Adrenergic Drugs For BSN 1 st Year Dr. Pravin Prasad 2 nd Year Resident, MD Clinical Pharmacology Maharajgunj Medical Campus 14 th March, 2017 (Chaitra 1, 2073), Tuesday

We will be discussing…. Overview of Adrenergic Transmission Adrenergic receptors Adrenergic Drugs

Adrenergic Transmission

Adrenergic Receptors Alpha ( α ) receptors Beta( β ) receptors Relative potency of agonists Adrenaline ( Adr ) ≥ Noradrenaline (NA )> Isoprenaline ( Iso ) Iso > Adr > NA Antagonists Phenoxybenzamine Propanolol Coupling Protein Go/ Gq / Gi Gs Effector Pathway IP 3 /DAG ( ↑), cAMP ( ↓ ), K + channel ( ↑) cAMP ( ↑ ), Ca 2+ channel ( ↑ )

Alpha ( α ) adrenergic receptors α 1 α 2 Location Post-junctional on effector organs Prejunctional Post-junctional Extra-junctional Functions GU smooth muscle contraction Vasoconstriction ↑ glandular secretion Relaxation of gut Glycogenolysis in liver Arrhythmia in heart Inhibitor of transmitter release Vasoconstriction Decreased sympathetic flow Decreased insulin release Platelet aggregation

Beta( β ) adrenergic receptors β 1 β 2 β 3 Location Heart JG cells in kidney Bronchi Blood vessels Uterus Liver Gastro-intestinal tract Urinary tract Eye Adipose tissue

Adrenergic responses Alpha ( α ) receptors Beta ( β ) receptors Rise in BP Fall in BP Little action on heart, arrhythmia at high doses ↑ rate, force and conduction velocity of heart - Bronchodilation Mydriasis, decreased aqueous secretion No effect on iris, relaxation of ciliary muscles, enhanced aqueous secretion

Adrenergic responses Alpha ( α ) receptors Beta ( β ) receptors Intestinal relaxation, contraction of sphincters Intestinal relaxation Bladder trigone contraction Detrusor relaxation Uterus contraction Relaxation

Adrenergic responses Alpha ( α ) receptors Beta ( β ) receptors Splenic capsule contraction Relaxation NM transmission facilitated Active state prolonged in fast contracting fibres, abbreviated in slow contracting fibres Decreased insulin secretion Augmented insulin and glucagon secretion

Adrenergic Drugs: Types Direct Acting Sympathomimetics Indirect acting sympathomimetics Mixed action sympathomimetics Adr , NA, Iso , Phenylephrine, Xylometazoline, Salbutamol Tyramine, Amphetamine Ephedrine, Mephentermine

Adrenergic drugs: overall actions Heart ( β 1 ) Increases HR Activates latent pacemakers – arrhythmia at higher doses Force of contraction, cardiac output and oxygen consumption- increased Increased conduction velocity – may overcome partial heart block

Adrenergic drugs: overall actions Blood vessels Vasoconstriction ( α 1 and α 2 ): cutaneous, mucous membrane, renal beds Vasodilation ( β 2 ): skeletal muscles, liver, coronaries Action more marked in arterioles and precapillary sphincters Blood Pressure NA: rise in systolic, diastolic and mean BP ( α ) Iso : rise in systolic BP, marked fall in diastolic BP ( β 1 & β 2 ) Adr : (slow i.v. ) rise in systolic, fall in diastolic, mean BP rises

Adrenergic drugs: overall actions Respiration Adr & Iso : potent bronchodilator ( β 2 ) Adr : Bronchial mucosa decongestant Toxic dose of Adr : pulmonary edema Eye Mydriasis ( α 1 : radial muscle contraction; poor with Adr ) Reduced aqueous formation and outflow facilitated

Adrenergic drugs: overall actions Metabolic Causes glycogenolysis : hyperglycaemia, hyperlactacidemia Lipolysis: rise in plasma free fatty acids, calorigenesis Transient hyperkalemia followed by hypokalemia

Adrenaline: Adverse Effects s.c. / i.m . injection: Transient restlessness, headache, palpitation, anxiety, tremor and pallor Marked rise in BP leading to CVA, VT/VF, angina Large doses or inadvertent i.v. injection of Adr  myocardial infarction

Adrenaline: Contraindications Should not be given: During general anaesthesia (halothane): risk of arrhythmia Patients receiving β blockers : marked rise in BP Contraindications: Hypertension Hyperthyroid Angina patients

Therapeutic Classification: Adrenergic Drugs Therapeutic Class Examples Pressor agents Noradrenaline, Phenylephrine, Ephedrine, Methoxamine, Dopamine, Mephentermine Cardiac stimulants Adrenaline, Dobutamine , Isoprenaline Bronchodilators Isoprenaline , Salmeterol, Salbutamol, Formeterol , Bambuterol , Terbutaline Nasal decongestants Phenylephrine, Naphazoline , Xylometazoline , Pseudoephedrine, Oxymetazoline , Phenylpropanolamine CNS stimulants Amphetamine, Methamphetamine, Dexamphetamine Anorectics Fenfluramine , Sibutramine , Dexfenfluramine Uterine relaxant Ritodrine , salbutamol, Isosuxprine , Terubtaline

Dopamine Dopaminergic (D 1 and D 2 ) and adrenergic ( α and β 1 ) agonist Increases g.f.r. and exerts natriuretic effects (D 1 ) Normal doses: raises cardiac output and systolic BP Moderately High Doses: Positive inotropic effect Uses Cardiogenic or septic shock Severe CHF

Dobutamine Derivative of Dopamine Selective β 1 agonist Uses- As an inotropic agent in pump failure accompanying: Myocardial Infarction Cardiac surgery Short term management of severe congestive heart failure

Ephedrine Mixed sympathomimetic drug; mainly acts indirectly Shows tachyphylaxis Effective orally Uses Mild bronchial asthma Hypotension during spinal anesthesia Occasionally for postural hypotension

Phenylephrine Selective α 1 agonist: raises BP due to vasoconstriction Reduces intra-ocular pressure Can be given orally as nasal decongestants Topical uses: Nasal decongestants Mydriasis without Cycloplegia Side effects:- After congestion seen

Nasal Decongestants α agonist- topically produces local vasoconstriction Selective α 2 agonists ( naphazoline , xylometazoline , oxymetazoline ): longer duration of action Lesser after congestion Side Effects: Initial stinging, Impairs mucosal ciliary function on prolonged use: atrophic rhinitis and anosmia; Systemic side effects: CNS depression, fall in BP

Indications: Vascular Uses Hypotensive states (shock, spinal anaesthesia, hypotensive drugs) Along with local anaesthetics Control of local bleeding Nasal Decongestants

Indications: Cardiac Use Cardiac arrest (drowning, electrocution, etc.) In combination with external cardiac massage Partial or complete A-V block Isoprenaline as temporary measure Congestive Heart Failure

Indications Bronchial asthma Allergic disorders (histamine mediated) Mydriatic Fundus examination Wide angle glaucoma

Indications Insulin Hypoglycaemia Nocturnal enuresis in children and urinary incontinence Amphetamine Uterine relaxant Ritoridine : to postpone labour Isosuxprine : threatened abortion and dysmenorrhoea

Indications: Central Uses Attention Deficit Hyperkinetic Disorders Amphetamine Narcolepsy Amphetamine, Modafinil Imipramine like drugs Epilepsy Amphetamines Parkinsonism Amphetamine Obesity Considered in severe obesity

Any queries?? Next Topic: Overview of Anti-adrenergic drugs Drugs used in Glaucoma Thank you!!
Tags